Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
18 hedge funds and large institutions have $1.96M invested in Acer Therapeutics Inc in 2013 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
120% more capital invested
Capital invested by funds: $893K → $1.96M (+$1.07M)
29% more funds holding
Funds holding: 14 → 18 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sophrosyne Capital
New York
|
+$391K |
| 2 |
California Public Employees Retirement System
Sacramento,
California
|
+$361K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$232K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$117K |
| 5 |
SIM
Spark Investment Management
New York
|
+$73.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TMC
Trellus Management Company
Delray Beach,
Florida
|
-$35K |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
-$34K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$23K |
| 4 |
Citigroup
New York
|
-$4.23K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$3.09K |
ACER Hedge Fund Activity: Q4 2013 in Review
18 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q4 2013, worth a combined $1.96M — up 120% from $893K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ACER positions and 3 closed out — a net gain of 4 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Sophrosyne Capital, opening a new position worth an estimated $391K. The largest seller was Trellus Management Company, exiting entirely with an estimated $35K sold.
- 18 institutional investors held Acer Therapeutics Inc (ACER) as of Q4 2013, up from 14 in Q3 2013.
- Funds reported $1.96M of Acer Therapeutics Inc stock for Q4 2013, up 120% quarter-over-quarter.
- 7 funds opened new Acer Therapeutics Inc positions in Q4 2013 and 3 closed out, a net change of +4 holders.
- The largest Acer Therapeutics Inc buyer in Q4 2013 was Sophrosyne Capital, an estimated $391K added.
- The largest Acer Therapeutics Inc seller in Q4 2013 was Trellus Management Company, an estimated $35K sold.
Based on aggregated 13F filings for Q4 2013.